Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Atterx Biotherapeutics Inc.
DescriptionNot disclosed
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationUrinary tract infection (UTI)
Indication DetailsTreat catheter-associated urinary tract infection (UTI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today